Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Ostman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Chemistry and Laboratory Medicine|January 30, 2003
Amyloid: morphology and toxicityAnders Olofsson, Johan Ostman, Erik Lundgren
The Journal of Biological Chemistry|December 4, 2004
Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?Mantas Malisauskas, Johan Ostman, Adas Darinskas, et al.
Neuron|December 6, 2006
SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypesCaroline R Fertleman, Mark D Baker, Keith A Parker, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Chemistry and Laboratory Medicine|January 30, 2003
Amyloid: morphology and toxicityAnders Olofsson, Johan Ostman, Erik Lundgren
The Journal of Biological Chemistry|December 4, 2004
Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?Mantas Malisauskas, Johan Ostman, Adas Darinskas, et al.
Neuron|December 6, 2006
SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypesCaroline R Fertleman, Mark D Baker, Keith A Parker, et al.
Pageof 1